A lump near the jaw is one of the more commonly misread findings in medicine, and a public correction this week illustrates why.
DevilDriver and Coal Chamber frontman Dez Fafara wrote on July 29 that he has "a tumor THAT'S NOT CANCER ON MY SALIVA GLAND," correcting outlets that had reported a brain tumor. Several publications had run the brain framing, and at least one headline still described it that way after the correction.
The distinction is not a technicality. A mass near the jawline and a mass in the brain are different organs, different specialties, different prognoses, and different operations. The confusion is understandable, though, because Fafara has said the tumor was found on an MRI ordered after a vertigo episode, and because the risks he described from surgery sound neurological.
They are neurological, in a specific and instructive way.
The Nerve That Runs Through the Gland
Describing the anatomy explains almost everything else about how these tumors are managed.
The parotid gland is the largest salivary gland, sitting just in front of and below the ear, extending toward the jawline. The facial nerve, the seventh cranial nerve, exits the skull base and passes directly through the parotid gland, splitting into branches that fan across the face like fingers.
Those branches control facial expression. One raises the eyebrow. One closes the eyelid. One moves the corner of the mouth. One controls the lower lip. Damage to any of them produces weakness or paralysis in that specific territory, and the eyelid branch matters disproportionately, because an eye that cannot fully close is at risk of corneal injury.
This is why a tumor sitting in a salivary gland produces surgical risks that sound like brain surgery risks. Fafara described the concern in exactly those terms, saying an operation could affect "my blinking, my smiling, my speaking."
A parotid operation is therefore largely an exercise in nerve dissection. The surgeon identifies the facial nerve trunk, traces each branch, and separates tumor from nerve. Temporary weakness after surgery is common. Permanent weakness is less common but real, and the risk rises when the tumor sits deep in the gland, is large, or is being removed a second time.
Most Salivary Masses Are Benign, but Not All
Salivary gland tumors are uncommon overall, and the odds vary sharply by which gland is involved.
In the parotid gland, the large majority of tumors are benign. The most common benign type is pleomorphic adenoma. The proportion of malignancy rises as the glands get smaller: submandibular gland tumors are malignant more often than parotid tumors, and tumors of the minor salivary glands scattered through the mouth and throat carry the highest malignancy rate of all.
Evaluation typically involves imaging, usually MRI for soft tissue detail, and a tissue sample obtained by fine needle aspiration or core biopsy. That combination is what distinguishes benign from malignant, and it is the step that determines everything downstream. Fafara has described undergoing testing and receiving a non-cancerous result.
Features that raise concern for malignancy include rapid growth, pain, fixation to surrounding tissue, skin involvement, enlarged neck lymph nodes, and, most significantly, facial weakness present before any surgery. A tumor that is already impairing the nerve is behaving in a way benign tumors usually do not.
Observation Is a Real Strategy, with Real Conditions
Watchful waiting for a benign salivary gland tumor is a legitimate approach in selected patients, and it is worth being precise about when.
Observation with interval imaging is generally considered for older patients, for people with significant surgical risk from other medical conditions, for small tumors in difficult locations, and for patients who choose it after understanding the trade-offs. The reasoning is that the operation itself carries facial nerve risk, and in some patients that risk outweighs the benefit of removing a slow-growing benign mass.
The trade-offs are real in both directions. Pleomorphic adenomas grow slowly and can, over long periods, undergo malignant transformation, which is why observation means scheduled imaging rather than ignoring it. Larger tumors are also technically harder to remove, so waiting can increase surgical difficulty later.
That last point deserves a note. Fafara has said his doctors told him the tumor needs to grow before it can be safely removed. MedicalDaily is reporting his account, not evaluating it, and cannot know the specifics of his imaging or the reasoning of his care team. As a general matter, however, surgeons more often cite tumor size as a reason to operate sooner rather than later, and readers should not take that particular rationale as a rule that applies to their own situation. Any two salivary tumors can differ in location, depth, and relationship to the nerve in ways that change the calculus entirely.
One further point belongs here because of how it will be read. Fafara has said he is working to shrink the tumor through diet, positivity, and prayer, and that it has been shrinking. No diet has been shown in clinical research to shrink salivary gland tumors, and apparent size differences between scans can reflect measurement variation, imaging technique, or normal fluctuation. People find real strength in faith and in feeling active in their own care, and that has genuine value. It should not be mistaken for tumor treatment, and no one should delay evaluation of a neck or jaw mass on the expectation that lifestyle changes will resolve it.
Signs That Warrant a Prompt Evaluation
Any new lump in front of or below the ear, along the jawline, or under the jaw that persists beyond two to three weeks should be examined by a clinician. Most will turn out to be benign, and many will be swollen lymph nodes or a blocked salivary duct rather than a tumor, but persistence is the trigger.
Features that warrant faster attention include a mass that is growing quickly, pain in the area, numbness or weakness anywhere in the face, a lump that feels fixed rather than mobile, difficulty opening the mouth, or a lump accompanied by swollen neck nodes.
The right specialist is an otolaryngologist, also called an ear, nose, and throat surgeon, and for tumors specifically a head and neck surgeon. A primary care clinician can make that referral. Imaging and biopsy generally require it, so the referral is the practical first step rather than something to arrange independently.
On cost, MRI and biopsy for a documented neck mass are typically covered by commercial insurance and Medicare when clinically indicated, though prior authorization for MRI is common. Patients facing a denial can ask the ordering clinician to document the physical finding and duration, which is usually what determines approval.
What remains unknown in the public case that prompted this coverage is the specific tumor type, which has not been disclosed, and Fafara's account of the tumor shrinking has not been accompanied by any published clinical documentation. He has said he intends to continue touring. MedicalDaily does not report on individuals' private medical care beyond what they choose to disclose.
Frequently Asked Questions
Where are the salivary glands? The parotid gland sits in front of and below the ear toward the jawline. The submandibular gland sits under the jaw. Hundreds of minor glands line the mouth and throat.
Why does a salivary tumor threaten facial movement? The facial nerve passes directly through the parotid gland and branches across the face, controlling eyebrow, eyelid, mouth, and lip movement. Surgery requires dissecting around it.
Are most salivary gland tumors cancerous? Most parotid tumors are benign. The likelihood of malignancy increases in the submandibular gland and is highest in the minor salivary glands.
How are they diagnosed? Usually with imaging, often MRI, plus a tissue sample obtained by fine needle aspiration or core biopsy. That combination distinguishes benign from malignant.
Is watchful waiting a real option? Yes, in selected cases, with scheduled interval imaging. It is considered for older patients, higher surgical risk, or certain tumor locations, and is a decision made with a surgeon.
Can diet shrink a salivary gland tumor? No diet has been shown in clinical research to shrink these tumors. Apparent changes between scans can reflect measurement variation.
When should someone see a doctor about a lump? Any lump near the ear or jaw persisting beyond two to three weeks. Rapid growth, pain, facial weakness or numbness, or a fixed mass warrant faster evaluation.
